What’s New

News

Jan 8, 2024

Alimentiv Announces Pierre Gaudreault as New Chief Executive Officer

London, Ontario, Canada, January 8, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce the appointment of Pierre Gaudreault as its Chief Executive Officer, effective January 2024. Th…

News

Nov 8, 2023

Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials.

LONDON, ON, November 8, 2023 – Alimentiv Inc., AcelaBio Inc., and PharmaNest Inc. are pleased to announce their collaborative effort aimed at revolutionizing precision medicine and artificial in…

Publication

Jun 15, 2023

Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn’s Disease: Systematic Review and Meta-Analysis

Brian G Feagan, Christopher Ma, Claire E Parker, Vipul Jairath.

Publication

Jun 15, 2023

Efficacy and safety of advanced oral small molecules for inflammatory bowel disease: Systematic review and meta-analysis

Brian G Feagan, Christopher Ma, Claire E Parker, Vipul Jairath.

Publication

Jun 2, 2023

Targeting IL-23 for IBD: Rationale and Progress to Date

Brian G Feagan, Christopher Ma, Vipul Jairath.

Publication

May 29, 2023

Effect of storage time on peripheral blood mononuclear cell isolation from blood collected in vacutainer CPT™ tubes

Niels Vande Casteele, Vipul Jairath, Wendy Teft.

Publication

May 29, 2023

Effect of storage time on peripheral blood mononuclear cell isolation from blood collected in vacutainer CPT™ tubes

Niels Vande Casteele, Vipul Jairath, Wendy Teft.

Publication

May 29, 2023

Standardizing Scoring Conventions for Crohn’s Disease Endoscopy: An International RAND/UCLA Appropriateness Study

Brian G Feagan, Christopher Ma, Geert D’Haens, Guangyong Zou, Vipul Jairath.